These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17003363)

  • 1. The alpha-adducin gene is associated with macrovascular complications and mortality in patients with type 2 diabetes.
    Yazdanpanah M; Sayed-Tabatabaei FA; Hofman A; Aulchenko YS; Oostra BA; Stricker BH; Pols HA; Lamberts SW; Witteman JC; Janssen JA; van Duijn CM
    Diabetes; 2006 Oct; 55(10):2922-7. PubMed ID: 17003363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha -308G>A polymorphism modulates cytokine serum concentrations and macrovascular complications in diabetic patients on aspirin.
    Krayenbuehl PA; Wiesli P; Schmid M; Schmid C; Ehses JA; Hersberger M; Vetter W; Schulthess G
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):322-6. PubMed ID: 17516296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of alpha-adducin and angiotensin converting enzyme gene polymorphisms with salt-sensitive hypertension and early renal injury].
    Lu LH; Chen H; Yu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):132-5. PubMed ID: 18393230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CETP TaqIB polymorphism is associated with the risk of sudden death in type 2 diabetic patients.
    Porchay-Baldérelli I; Péan F; Bellili N; Jaziri R; Marre M; Fumeron F;
    Diabetes Care; 2007 Nov; 30(11):2863-7. PubMed ID: 17666459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea.
    Becker ML; Aarnoudse AJ; Newton-Cheh C; Hofman A; Witteman JC; Uitterlinden AG; Visser LE; Stricker BH
    Pharmacogenet Genomics; 2008 Jul; 18(7):591-7. PubMed ID: 18551039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of genetic variation in adducin on left ventricular diastolic function as assessed by tissue Doppler imaging in a Flemish population.
    Kuznetsova T; Citterio L; Herbots L; Carpini SD; Thijs L; Casamassima N; Richart T; Fagard RH; Bianchi G; Staessen JA
    J Hypertens; 2008 Jun; 26(6):1229-36. PubMed ID: 18475162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the renin-angiotensin system genes and salt sensitivity genes on blood pressure and atherosclerosis in the total population and patients with type 2 diabetes.
    Yazdanpanah M; Aulchenko YS; Hofman A; Janssen JA; Sayed-Tabatabaei FA; van Schaik RH; Klungel OH; Stricker BH; Pols HA; Witteman JC; Lamberts SW; Oostra BA; van Duijn CM
    Diabetes; 2007 Jul; 56(7):1905-12. PubMed ID: 17446534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study.
    Spijkerman AM; Henry RM; Dekker JM; Nijpels G; Kostense PJ; Kors JA; Ruwaard D; Stehouwer CD; Bouter LM; Heine RJ
    J Intern Med; 2004 Nov; 256(5):429-36. PubMed ID: 15485479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients.
    Cyganek K; Mirkiewicz-Sieradzka B; Malecki MT; Wolkow P; Skupien J; Bobrek J; Czogala M; Klupa T; Sieradzki J
    Acta Diabetol; 2006 Dec; 43(4):114-9. PubMed ID: 17211561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of alpha-adducin Gly460Trp polymorphism with coronary artery disease in a Korean population.
    Cha SH; Kim HT; Jang Y; Park S; Kim JJ; Song MY; Park JH; Ryu HJ; Park HY; Yoon SJ; Kimm K; Lee JK; Oh B
    J Hypertens; 2007 Dec; 25(12):2413-20. PubMed ID: 17984662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.
    Mäkelä R; Loimaala A; Nenonen A; Mercuri M; Vuori I; Huhtala H; Oja P; Bond G; Koivula T; Lehtimäki T
    Clin Biochem; 2008 May; 41(7-8):532-7. PubMed ID: 18280811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study.
    Ringborg A; Lindgren P; Martinell M; Yin DD; Schön S; Stålhammar J
    Diabet Med; 2008 Oct; 25(10):1178-86. PubMed ID: 19046196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular risk.
    van Rijn MJ; Bos MJ; Yazdanpanah M; Isaacs A; Arias-Vásquez A; Koudstaal PJ; Hofman A; Witteman JC; van Duijn CM; Breteler MM
    Stroke; 2006 Dec; 37(12):2930-4. PubMed ID: 17082469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alpha-adducin Gly460Trp polymorphism and the antihypertensive effects of exercise among men with high blood pressure.
    Pescatello LS; Blanchard BE; Tsongalis GJ; Maresh CM; O'Connell A; Thompson PD
    Clin Sci (Lond); 2007 Sep; 113(5):251-8. PubMed ID: 17472579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.
    Cardoso CR; Salles GF
    J Diabetes Complications; 2008; 22(3):164-70. PubMed ID: 18413219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-erythrocyte cation concentrations in relation to the C1797T beta-adducin polymorphism in a general population.
    Richart T; Thijs L; Kuznetsova T; Tikhonoff V; Zagato L; Lijnen P; Fagard R; Wang J; Bianchi G; Staessen JA
    J Hum Hypertens; 2007 May; 21(5):387-92. PubMed ID: 17301826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.